Spreadex Market Update

AstraZeneca and RBS lift FTSE, tough morning for BT and Thomas Cook




Royal Bank of Scotland surged by 3% this morning following better than expected second quarter results, including net profit of £293 million. And whilst the bank reported a £153 million loss for the first half of the year, CEO Ross McEwan hopes that the fund-sapping bigger fines are coming to an end, something that would make the sale of the 80% government-owned bank more attractive.

Like Glaxo yesterday afternoon, AstraZeneca surprised investors with its second quarter results, as blood thinner Brilinta and its diabetes treatments came to the rescue. Earnings per share of $1.21 were much higher than the $1.06 forecast, even if it does equate to a $0.09 fall year-on-year, whilst sales similarly avoided analysts’ worst fears, coming in at $6.31 billion to the $6.09 billion expected. These results helped lift Astra by around 2%, as it and its pharma-giant rival Glaxo try and escape the sluggish trading that has plagued them in the last few months.

It wasn’t all investor-pleasing news this Thursday; despite seeing a 16% jump in pre-tax profits to £632 million, BT Group slipped by over 2% after the bell. This disappointment could perhaps be attributed to the 2% drop in revenue seen by the media company, a decline that becomes more egregious when compared to the staggering growth shown by Sky in its fiscal full year results yesterday. Thomas Cook similarly suffered this morning, slipping by 3% after the holiday company warned that the tragic violence in Tunisia, and the ongoing struggles with Greece, will cost it around £25 million across the year.

Over in the Eurozone, and the DAX received a similar boost to its UK colleague, with a 3% jump for Deutsche Bank following the news that its net profit had more than tripled year-on-year to €796 million pushed the German index towards 3 digit gains. With the head negotiators from the IMF set to arrive in Greece today, technical talks should continue, the hope being that this preliminary stage will be completed by Friday; if so, then next week should, in theory, bring some more of the Greek action that the Eurozone had got so used to in the past few months.


DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.